Noticias

Antonio Ciaglia, el Director de Política de IAPO, explora por qué la confianza debe ser el núcleo de las relaciones entre doctores y pacientes, y cómo esto debería ser un pilar fundamental de la asistencia sanitaria centrada en el paciente.
During June 2016, several IAPO representatives attended the BIO International Convention in San Francisco, California. Developments in San Francisco’s Genomic Valley promise to have a ‘disruptive’ effect on current drug research, the development process, and the way the established pharmaceutical...
We are pleased to announce that Hussain Jafri , from Alzheimer's Pakistan, and Bejon Misra , from Consumer Online Foundation (India), will be joining the IAPO Governing Board in August 2016.
IAPO members represent patients around the world and often deal with challenges such as funding cuts, changes in administrations and wider economic uncertainty.
Muchas de las estrategias de abogacía del paciente e intervenciones usadas hoy en día fueron inicialmente desarrolladas en el Distrito Castro en San Francisco, California, EEUU, en los años ochenta. Hoy en día una enorme bandera con los colores del arco iris ondea orgullosa sobre El Castro, proclamando su confianza, vitalidad y espíritu comunitario.
In the 1980s, the Castro District of San Francisco was under attack from an unknown and devastating disease that was killing its young men, and attacked by the media, politicians and society that forced it to the brink of collapse.
We will be welcoming Hussain Jafri, Secretary General for Alzheimer's Pakistan, to our Governing Board in August 2016.
We will be welcoming Bejon Misra, the founder of the Consumer Online Foundation, India, to our Governing Board in August 2016. Bejon answered a few questions about his work, what he brings to IAPO and why he is involved in patient advocacy work.
En el Día Mundial de la Hepatitis, 28 julio 2016, la Alianza Mundial Contra la Hepatitis junto con muchas otras organizaciones de la sociedad civil lanzará un movimiento global con el fin de eliminar la hepatitis viral antes del 2030. ​

Pages